EPO--one year later. Part II. Balancing the costs and benefits

Nephrol News Issues. 1990 Jun;4(6):22, 38.
No abstract available

MeSH terms

  • Cost-Benefit Analysis / economics
  • Costs and Cost Analysis / economics
  • Erythropoietin / therapeutic use*
  • Humans
  • Kidney Failure, Chronic / economics
  • Kidney Failure, Chronic / therapy
  • Renal Dialysis / economics

Substances

  • Erythropoietin